Amanote Research
Register
Sign In
The Endothelin B (ETB) Receptor Agonist IRL 1620 Is Highly Vasoconstrictive in Two Syngeneic Rat Tumour Lines: Potential for Selective Tumour Blood Flow Modification
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6602672
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 21, 2005
Authors
M Cemazar
I Wilson
V E Prise
K M Bell
S A Hill
G M Tozer
Publisher
Springer Science and Business Media LLC
Related search
Attenuation of Opioid Tolerance by ET B Receptor Agonist, IRL-1620, Is Independent of an Accompanied Decrease in Nerve Growth Factor in Mice
Heliyon
Multidisciplinary
Characterization of the Binding of Endothelin ETB Selective Ligands in Human and Rat Heart
British Journal of Pharmacology
Pharmacology
Effect of Solubilized Membrane Antigens and Tumour Bearer Serum on Tumour Growth in Syngeneic Hosts
British Journal of Cancer
Cancer Research
Oncology
Caspase-8 Expression Is Predictive of Tumour Response to Death Receptor 5 Agonist Antibody in Ewing’s Sarcoma
British Journal of Cancer
Cancer Research
Oncology
The Tumour Trail Left in Blood
Nature
Multidisciplinary
Enhancement of Tumour Growth in Two Syngeneic C3H Murine Systems by Immunization via the Intracaecal Route
British Journal of Cancer
Cancer Research
Oncology
Effect of Selective Blockade of Endothelin ETB Receptors on the Liver Dysfunction and Injury Caused by Endotoxaemia in the Rat
British Journal of Pharmacology
Pharmacology
Intense Tumour-Cell Destruction by Syngeneic Mice: Role of Macrophages, Complement Activation and Tumour-Cell Factors
British Journal of Cancer
Cancer Research
Oncology
Relationship Between Tumour Endothelial Cell Apoptosis and Tumour Blood Flow Shutdown Following Treatment With the Antivascular Agent DMXAA in Mice
British Journal of Cancer
Cancer Research
Oncology
